Open Access

[Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells

  • Authors:
    • Feng Tian
    • Ding Ding
    • Dandan Li
  • View Affiliations

  • Published online on: July 17, 2023     https://doi.org/10.3892/ijo.2023.5547
  • Article Number: 99
  • Copyright : © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2023
Volume 63 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tian F, Ding D and Li D: [Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells. Int J Oncol 63: 99, 2023
APA
Tian, F., Ding, D., & Li, D. (2023). [Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells. International Journal of Oncology, 63, 99. https://doi.org/10.3892/ijo.2023.5547
MLA
Tian, F., Ding, D., Li, D."[Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells". International Journal of Oncology 63.3 (2023): 99.
Chicago
Tian, F., Ding, D., Li, D."[Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells". International Journal of Oncology 63, no. 3 (2023): 99. https://doi.org/10.3892/ijo.2023.5547